BME Stock Overview
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
BlackRock Health Sciences Trust Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$39.04 |
| 52 Week High | US$43.20 |
| 52 Week Low | US$35.53 |
| Beta | 0.68 |
| 1 Month Change | -4.83% |
| 3 Month Change | -4.71% |
| 1 Year Change | -8.29% |
| 3 Year Change | -18.41% |
| 5 Year Change | 0.36% |
| Change since IPO | 56.10% |
Recent News & Updates
BME: Trading At A Historical Discount To NAV
Apr 05BME: Historically One Of The Best Times For Entry
Nov 28BME: BlackRock's Health Sciences Fund Is A Solid Alternative To Pricey THW
Sep 17BME Offers A Good Mix Of High Yield And Market-Beating Total Returns
Jul 03BME: Well-Positioned Healthcare CEF For Monthly Income
Feb 10Recent updates
BME: Trading At A Historical Discount To NAV
Apr 05BME: Historically One Of The Best Times For Entry
Nov 28BME: BlackRock's Health Sciences Fund Is A Solid Alternative To Pricey THW
Sep 17BME Offers A Good Mix Of High Yield And Market-Beating Total Returns
Jul 03BME: Well-Positioned Healthcare CEF For Monthly Income
Feb 10BlackRock Health Sciences Trust declares $0.213 dividend
Dec 12BlackRock Health Sciences Trust goes ex-dividend on Monday
Nov 11BlackRock Health Sciences Trust declares $0.213 dividend
Oct 06BME: Overpriced Health-Care CEF, Paltry 6% Yield
Sep 21BlackRock Health Sciences Trust declares $0.213 dividend
Sep 02BlackRock Health Sciences Trust declares $0.213 dividend
Aug 05BME And BMEZ: 2 Quite Different Choices
Jul 26BlackRock Health Sciences Trust declares $0.213 dividend
Jul 05BME: Good Times, Bad Times, A Fund For All Times
Apr 24BME: High Concentration In Large Cap Led To Huge Downfall
Mar 03BMEZ: We Own BME, But Here's Why We're Buying BlackRock Health Sciences Trust II
Dec 24BME: High Yield And Strong Growth From Healthcare
Dec 14BlackRock Health Sciences: Clever Options Strategies And Asset Allocation
Sep 19Evaluating CEFs: BME Offers Good Income In A Hot Sector
Jun 18BlackRock Health Sciences Trust declares $0.20 dividend
May 07BlackRock Health Sciences Trust declares $0.20 dividend
Feb 04BlackRock Health Sciences Trust declares $0.20 dividend
Jan 05BME: Monthly Dividends Plus Growth
Dec 15BlackRock Health Sciences Trust declares $0.20 dividend
Dec 04BlackRock Health Sciences Trust declares $0.20 dividend
Nov 03Shareholder Returns
| BME | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 0.8% | 1.9% | 1.0% |
| 1Y | -8.3% | 28.1% | 21.9% |
Return vs Industry: BME underperformed the US Capital Markets industry which returned 31.6% over the past year.
Return vs Market: BME underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| BME volatility | |
|---|---|
| BME Average Weekly Movement | 1.7% |
| Capital Markets Industry Average Movement | 3.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BME has not had significant price volatility in the past 3 months.
Volatility Over Time: BME's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | n/a | www.blackrock.com/investing/products/240227/blackrock-health-sciences-trust-usd-fund |
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
BlackRock Health Sciences Trust Fundamentals Summary
| BME fundamental statistics | |
|---|---|
| Market cap | US$490.59m |
| Earnings (TTM) | US$20.02m |
| Revenue (TTM) | US$8.19m |
24.5x
P/E Ratio59.9x
P/S RatioIs BME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BME income statement (TTM) | |
|---|---|
| Revenue | US$8.19m |
| Cost of Revenue | US$0 |
| Gross Profit | US$8.19m |
| Other Expenses | -US$11.82m |
| Earnings | US$20.02m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.59 |
| Gross Margin | 100.00% |
| Net Profit Margin | 244.30% |
| Debt/Equity Ratio | 0.01% |
How did BME perform over the long term?
See historical performance and comparison